ciltacabtagene autoleucel
janssen
['cartitude-2', 'cilta-cel']
icymi: new data from cartitude-2, cohort a shows promise for cilta-cel as an earlier line of tx in mutiple myeloma. read more from #asco22 here: 
CGTLive™ delivers quality and relevant information to healthcare professionals on cell, gene, regenerative, and engineered medicines to ultimately improve care.